![Jason Hoitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Hoitt
Corporate Officer/Principal bei
STOKE THERAPEUTICS, INC.
Vermögen: 336 231 $ am 30.06.2026
Profil
Jason Hoitt currently works at Stoke Therapeutics, Inc., as Chief Patient Officer from 2025.
Mr. Hoitt also formerly worked at Sarepta Therapeutics, Inc., as Head-US Sales from 2013 to 2017, Insmed, Inc., as Vice President & Head-US Sales, Dova Pharmaceuticals, Inc., as Chief Commercial Officer from 2018 to 2019, and Provention Bio, Inc., as Chief Commercial Officer from 2020 to 2023.
Mr. Hoitt received his undergraduate degree in 1999 from College of the Holy Cross (Massachusetts).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 10’276 ( 0.02% ) | 336 231 $ | 30.06.2026 |
Aktive Positionen von Jason Hoitt
| Unternehmen | Position | Beginn |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Corporate Officer/Principal | 15.04.2024 |
Ehemalige bekannte Positionen von Jason Hoitt
| Unternehmen | Position | Ende |
|---|---|---|
| PROVENTION BIO, INC. | Corporate Officer/Principal | 01.06.2023 |
| DOVA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 12.11.2019 |
| INSMED INCORPORATED | Vertrieb & Marketing | - |
| SAREPTA THERAPEUTICS, INC. | Vertrieb & Marketing | 01.05.2017 |
Ausbildung von Jason Hoitt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
